Fractyl Health Inc.

GUTS | undefined

Price Alert Chart Builder DCF Calculator

At close: undefined

After-hours:

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

undefined%

(1Y)

Rating

Updated: Aug 11, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $-

1D Range

52W Range

Valuation (TTM)

PE -0.43

PB -54.47

EV/EBITDA -1.00

Valuation (NTM)

Forward PE N/A

Forward PEG -0.03

Price Target $5

Cash Flow

FCF Yield -90.9%

SBC Adj. FCF Yield -100.3%

SBC Impact -10.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -131.3% | -14.1%

Dil EPS 3Y | 5Y -1.3% | -7.5%

FCF 3Y | 5Y -19.8% | -19.2%

Returns

ROA -128.9%

ROE -1625.9%

ROIC -120.3%

Financial Health

Net Debt

$13.6M

Current Ratio 3.15

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient proced...

Sector Healthcare

Industry Biotechnology

Employees 100

IPO Date Feb 1, 2024

Website fractyl.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

0.00%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞